Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data

BMC Health Services Research

Volumn 16, Issue 1, 2016, Pages

  Sancho Mestre, Carla ^a   Vivas Consuelo, David ^a   Alvis Estrada, Luis ^b   Romero, Martin ^c   Usó Talamantes, Ruth ^d   Caballer Tarazona, Vicent ^a  

^a UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

^c Center in Health Economics Investigator   (Colombia)

^d Health Department (Conselleria de Sanitat)   (Spain)

Author keywords

Diabetes mellitus; Multiborbidity; Pharmaceutical expenditure

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG COST; ECONOMICS; ELECTRONIC HEALTH RECORD; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; MALE; PREVALENCE; SPAIN; STATISTICS AND NUMERICAL DATA;

AGED; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG COSTS; ELECTRONIC HEALTH RECORDS; FEMALE; HEALTH EXPENDITURES; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PREVALENCE; SPAIN;

EID: 84982128252     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-016-1649-2     Document Type: Article

References (32)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22079683
2. Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55:88-93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21987347
3. WHO | Rio Political Declaration on Social Determinants of Health. WHO. World Health Organization; 2011. Available from: http://www.who.int/sdhconference/declaration/Rio-political-declaration.pdf?ua=1
4. Fortin M, Soubhi H, Hudon C, Bayliss EA, van den Akker M. Multimorbidity's many challenges. BMJ. 2007;334:1016-7. BMJ Group [cited 2016 Aug 4]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17510108
5. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7:357-63. [cited 2016 Aug 4]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19597174
6. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288-94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15617955
7. Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, et al. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28:516-23. [Internet]. 2011 [cited 2016 Aug 4]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21436204
8. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43. [cited 2014 Nov 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/22579043
9. Holden L, Scuffham PA, Hilton MF, Muspratt A, Ng SK, Whiteford HA. Patterns of multimorbidity in working Australians. Popul Heal Metr. 2011;9:15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21635787
10. Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med. 2006;4:101-3. [cited 2016 Aug 4]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16569711
11. Abdul-Rahim HF, Holmboe-Ottesen G, Stene LCM, Husseini A, Giacaman R, Jervell J, et al. Obesity in a rural and an urban Palestinian West Bank population. Int J Obes. 2003;27:140-6. Available from: http://dx.doi.org/10.1038/sj.ijo.0802160
12. Boutayeb A, Boutayeb S, Boutayeb W. Multi-morbidity of non communicable diseases and equity in WHO Eastern Mediterranean countries. Int J Equity Heal. 2013;12:60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23961989
13. Teljeur C, Smith SM, Paul G, Kelly A, O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19:17-22. Available from: http://informahealthcare.com/doi/abs/10.3109/13814788.2012.714768, http://www.ncbi.nlm.nih.gov/pubmed/23432037
14. Hughes JS, Averill RF, Eisenhandler J, Goldfield NI, Muldoon J, Neff JM, et al. Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care. 2004;42:81-90. [cited 2016 Feb 29]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14713742
15. Vivas-Consuelo D, Alvis-Estrada L, Uso-Talamantes R, Caballer-Tarazona V, Buigues-Pastor L, Sancho-Mestre C. Multimorbidity Pharmaceutical Cost of Diabetes Mellitus. Value in Health. 2014;17:A341-2. Elsevier [cited 2016 Apr 21]. Available from: http://www.sciencedirect.com/science/article/pii/S1098301514026102
16. Inoriza JM, Pérez M, Cols M, Sánchez I, Carreras M. Análisis de la población diabética de una comarca: perfil de morbilidad, utilización de recursos, complicaciones y control metabólico. Aten Primaria. 2016;45. Available from: http://www.sciencedirect.com/science/article/pii/S0212656713001340
17. Vivas-Consuelo D, Usó-Talamantes R, Trillo-Mata JL, Caballer-Tarazona M, Barrachina-Martínez I, Buigues-Pastor L. Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Health Policy. 2014;116:188-95. Available from: http://www.sciencedirect.com/science/article/pii/S0168851014000256
18. Kho AN, Hayes MG, Rasmussen-Torvik L, Pacheco JA, Thompson WK, Armstrong LL, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc. 2016;19:212-8. [cited 2016 Feb 18]. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3277617&tool=pmcentrez&rendertype=abstract
19. Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, Poncel-Falcó A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7:e32190. Public Library of Science [cited 2016 Apr 21]. Available from: http://dx.doi.org/10.1371/journal.pone.0032190
20. Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9:e83783. Public Library of Science [cited 2016 Mar 25]. Available from: http://dx.doi.org/10.1371/journal.pone.0083783
21. Fortin M, Bravo G, Hudon C, Lapointe L, Dubois MF, Almirall J. Psychological distress and multimorbidity in primary care. Ann Fam Med. 2006;4:417-22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17003141
22. Nuttall M, van der Meulen J, Emberton M. Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol. 2006;59:265-73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16488357
23. Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013;36:914-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23193215
24. Alonso-Moran E, Orueta JF, Fraile Esteban JI, Arteagoitia Axpe JM, Luz Marques Gonzalez M, Toro Polanco N, et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health. 2014;14. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197247/
25. Pantalone KM, Hobbs TM, Wells BJ, Kong SX, Kattan MW, Bouchard J, et al. Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system. BMJ open diabetes Res Care. 2015;3:e000093. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4513350&tool=pmcentrez&rendertype=abstract
26. Alonso-Moran E, Satylganova A, Orueta JF, Nuno-Solinis R. Prevalence of depression in adults with type 2 diabetes in the Basque Country: relationship with glycaemic control and health care costs. BMC Public Health. 2014;14. Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-769
27. Kilzieh N, Rastam S, Maziak W, Ward KD. Comorbidity of depression with chronic diseases: a population-based study in Aleppo, Syria. Int J Psychiatry Med. 2008;38:169-84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18724568
28. Almawi W, Tamim H, Al-Sayed N, Arekat MR, Al-Khateeb GM, Baqer A, et al. Association of comorbid depression, anxiety, and stress disorders with Type 2 diabetes in Bahrain, a country with a very high prevalence of Type 2 diabetes. J Endocrinol Invest. 2008;31:1020-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19169060
29. Giralt Muiña P, Gutiérrez Ávila G, Ballester Herrera MJ, Botella Romero F, Angulo Donado JJ. Prevalencia de diabetes y diabetes oculta en adultos de Castilla-La Mancha. TITLEREVISTA. 2011;137:484-90. Available from: http://zl.elsevier.es/es/revista/medicina-clinica-2/prevalencia-diabetes-diabetes-oculta-adultos-castilla-la-mancha-90028329-originales-2011
30. Mata-Cases M, Roura-Olmeda P, Berengué-Iglesias M, Birulés-Pons M, Mundet-Tuduri X, Franch-Nadal J, et al. Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain. Int J Clin Pract. 2012;66:289-98. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3584513&tool=pmcentrez&rendertype=abstract
31. Egede LE, Gebregziabher M, Zhao Y, Dismuke CE, Walker RJ, Hunt KJ, et al. Differential Impact of Mental Health. 2015;21:535-44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26295353
32. Huber CA, Diem P, Schwenkglenks M, Rapold R, Reich O. Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland. Diabetes Metab Syndr Obes. 2014;7:455-65. Dove Press [cited 2016 Aug 4]. Available from: https://www.dovepress.com/estimating-the-prevalence-of-comorbid-conditions-and-their-effect-on-h-peer-reviewed-article-DMSO